View More Recent Stories
-
Hims & Hers Health (HIMS) Files Mixed Shelf
-
Truist Defending Viking Therapeutics (VKTX): 'recommend investors take advantage of today’s selloff to add to shares'
-
Hims & Hers Health, Inc. (HIMS) call put ratio 2.6 calls to 1 put after Eli Lilly & Co. (LLY) launches single-dose vials of Zepbound
-
Citi on Hims and Hers (HIMS) Post Lilly (LLY) News: 'Single-dose Zepbound Vials a Shot Across the Bow for the Compounders'
-
Hims & Hers Health, Inc. (HIMS) Declines 7%
-
Needham Starts Hims and Hers (HIMS) at Buy
-
Hims and Hers (HIMS) PT Lowered to $18 at Jefferies
-
Hims and Hers (HIMS) PT Raised to $23 at Deutsche Bank
-
After-hours movers: Palantir, ZoomInfo, Hims & Hers and more
-
Hims & Hers Health, Inc. (HIMS) Tops Q2 EPS by 2c, Offers Guidance
-
These stocks are near-term opportunity to invest in the GLP-1 space
-
Hims & Hers Health, Inc. (HIMS) Says 'Voluntarily Cooperating' With FTC Inquiry - Bloomberg
-
Hims and Hers (HIMS) PT Raised to $23 at Truist Securities
-
Hims and Hers (HIMS) PT Raised to $18 at Piper Sandler
-
Hims and Hers (HIMS) PT Raised to $25 at TD Cowen
-
Hims & Hers Health, Inc. (HIMS) option volume of 118K contracts elevated amid wide price movement
-
Hims & Hers Health, Inc. (HIMS) call put ratio 1 call to 1.1 puts with focus on July 20 puts
-
Hims & Hers Health, Inc. (HIMS) Mentioned Cautiously at Hunterbrook
-
Hims and Hers (HIMS) PT Raised to $26 at BofA Securities

